Natixis Advisors LLC has increased its stake in Ross Stores, Inc. by 8.6% in the fourth quarter, bringing its total holding to over 1.1 million shares worth approximately $213.5 million. This coincides with positive analyst sentiment, with many raising price targets and maintaining "Buy" or better ratings, resulting in a consensus target price of $233.18. Ross Stores recently posted strong quarterly results, exceeding EPS and revenue expectations, and announced a quarterly dividend.

Palo Alto Networks has finalized its acquisition of Portkey, an AI production firm. Portkey's technology will integrate with Palo Alto Networks' Prisma AIRS platform, functioning as an AI gateway to secure AI interactions and enforce governance policies. This acquisition aims to allow organizations to adopt AI capabilities safely and efficiently within their core business operations.

Vantus Wealth LLC has acquired 9,754 shares of Walmart Inc. (NASDAQ:WMT) for approximately $1.09 million, making it their 29th-largest holding and representing 0.8% of their portfolio. This purchase reflects continued strong institutional interest in Walmart, despite some insider selling. The company's business momentum is being driven by digital expansion, including drone deliveries and expanded 30-minute delivery services, leading to generally positive analyst ratings and raised price targets.

Ascendiant Capital has maintained a 'Buy' rating on Genasys (GNSS) and increased its price target from $5.50 to $6.00, indicating a positive outlook for the stock. Despite this, GuruFocus assesses GNSS as undervalued with a GF Value™ of $3.41 against a current price of $2.12, but also notes an average GF Score™ of 51/100, driven by low financial strength and growth metrics, suggesting a potential "value trap." Investors are advised to exercise caution and thoroughly evaluate risks.

Fulcrum Therapeutics' stock plummeted by 48% after the company announced it would discontinue pociredir, its lead drug candidate for sickle cell disease. The decision leaves Fulcrum Therapeutics with no products on the market, despite its efforts to commercialize the experimental drug. The company cited "no viable path forward" for the sickle cell treatment.

Verizon has extended the early participation date for its private exchange offers and consent solicitations for 11 series of notes to June 16, 2026. As of June 1, 2026, early tenders for these notes ranged from 0.96% to 85.89% of the principal outstanding across different series. The new notes will have the same economic terms as the old notes but will initially be unregistered, with participation limited to qualified institutional buyers and non-U.S. qualified investors.

Verizon has amended its 2026 debt tender offers and consent solicitations, extending the early participation date for 11 subsidiary notes to June 16, 2026, and increasing the Waterfall Cap to approximately $1.4 billion. The company also released early participation results, showing strong engagement with some note series seeing up to 97.03% tendered. All offers are set to expire on June 16, 2026.

Verizon Communications Inc. announced the extension of the early participation date for its private exchange offers and consent solicitations for 11 series of Old Notes until June 16, 2026. This extension allows eligible holders more time to tender their Old Notes to receive the Total Consideration, which includes an Early Participation Payment. The company also released early participation results, showing varying percentages of principal amounts tendered for each series of notes as of June 1, 2026.

Twin Peaks Wealth Advisors LLC has acquired a new position of 5,114 shares in Texas Instruments Incorporated, valued at approximately $887,000. This comes as several other institutional investors also increased their holdings in the semiconductor company, with hedge funds and institutional investors owning 84.99% of the stock. Despite a "Hold" consensus rating from analysts, Texas Instruments reported better-than-expected earnings and announced a quarterly dividend.

Thompson Siegel & Walmsley LLC reduced its stake in The TJX Companies, Inc. by 21.6% in the fourth quarter of 2025, selling 13,270 shares and retaining 48,306 shares valued at approximately $7.42 million. Despite this reduction, TJX reported strong quarterly results with EPS of $1.19 and revenue of $14.32 billion, surpassing analyst estimates. The company also increased its quarterly dividend to $0.48 per share, and Wall Street analysts generally maintain a "Buy" rating with an average price target of $174.58.